ADAP Advocacy Association CEO Brandon M. Macsata wrote this editorial, which appeared on the AIDS Drug Assistance Program’s website on April 1, 2021.
The Association first warned constituents that counterfeit Symtuza had been distributed to three U.S. pharmacies in December 2020, when Janssen issued an alert.[...]
This editorial by Brandon Macsata was published in The International Business Times on November 1, 2020. Macsata has been living with HIV since 2002, and serves as the CEO of the ADAP Advocacy Association, an organization that promotes the AIDS Drug Assistance Program and works to improve access to care.[...]
Immunodeficient patients need to strictly adhere to our prescribed drug protocols because any slip could compromise our current treatment plans. Only purchasing FDA-approved medicines from licensed U.S pharmacies is an essential step in keeping ourselves as healthy as possible…[...]
It isn’t just policymakers who believe drug importation will open the U.S. drug supply to counterfeits. In this editorial, published in the Times of Northwest Indiana on March 6, 2019, HIV-positive advocate Brandon Macsata explains that his own physician objected to ordering medicine from Canadian online pharmacies:
“It never crossed my mind that I might have been taking counterfeit medicine, or that the medicines meant to control my HIV could be compromising my immune system. So when my doctor found out, she told me to stop immediately. She warned me that online pharmacies often sell counterfeit drugs.”[...]
Brandon Macsata, the CEO of the AIDS Drug Assistance Program Advocacy Association, writes about the dangerous unreliability of imported medicines. (Originally published in the The Washington Blade and the ADAP blog.)[...]
This editorial by Scott Bertani was published in the Washington Herald on May 7, 2017. Mr. Bertani is the Director of Policy and Community Relations for Lifelong AIDS Alliance, a nonprofit health advocacy group based in Western Washington.[...]